Hereditary Genetic Changes and Somatic Mutations in Precision Oncology

Hereditary Genetic Changes and Somatic Mutations in Precision Oncology is organized by Florida Society of Pathologists (FSP).

Release Date: February 1, 2025
Expiration Date: February 1, 2026

Description:
This webinar will explore the critical role of genetic alterations in cancer development and treatment. Participants will gain a comprehensive understanding of the differences between inherited (germline) and acquired (somatic) mutations, their implications for precision oncology, and how to effectively detect them. The program will also highlight the tools and methodologies used to detect these genetic changes and provide strategies for collaborating with genetic counselors to incorporate hereditary risk assessments into cancer diagnosis and management.

Learning Objectives:
At the conclusion of this activity, learners should be better able to:

• Differentiate between oncogenic germline and somatic alterations (eg, BRCA, HRD).
• Review how germline and somatic alterations may be detected.
• Collaborate with genetic counselors to integrate hereditary risk assessment into cancer diagnosis.